CSF3 and Miyoshi myopathy: GPC-100, in combination with G-CSF, has been tested clinically in MM patients as an HSC mobilizer (NCT02104427) [25], and was shown to elicit a significant increase in HSCs with >5.0 x 106 CD34+ cells/kg in 1–2 leukapheresis sessions [26].